NVCR
NovoCure Ltd.
NASDAQ · Healthcare · Medical - Instruments & Supplies · JE
$14.90
+10.95%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.22x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.97x
- Price / sales
- 2.40x
- Price / cash flow
- 485.66x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- 2.08x
- EV / EBITDA
- -14.49x
- EV / EBIT
- -12.13x
- Market cap
- $1.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026